Back to results
US 11,992,487 B2Granted
Quinolines that modulate SERCA and their use for treating disease
AssigneeNeurodon Corporation
InventorRussell Dahl
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes.
Claims1
A pharmaceutical composition comprising:
- i) a compound of the following structural formula:
- or a pharmaceutically acceptable salt, solvate, or hydrate thereof;
- and
- ii) a pharmaceutically acceptable carrier, excipient or diluent.
1 more element
Dependencies are inferred from the claim text.